Effectiveness of ECP Therapy in Stable Angina Pectoris Patients
Effectiveness of External Counter Pulsation (ECP) Therapy in Stable Angina Pectoris Patients; a Proof of Principal Clinical Trial
Universitas Padjadjaran
84 participants
Jul 1, 2023
INTERVENTIONAL
Conditions
Summary
External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time. Utilization of ECP for such patients who wait for CABG procedure is still unclear. The investigator aim to evaluate efficacy of addition of ECP compared with medical therapy alone for this population. The efficacy is evaluated using measurement from echocardiography result, treadmill test result, and clinical outcome. if applicable, examination of myocardial perfusion using nuclear examination will also be performed.
Eligibility
Inclusion Criteria9
- Age >= 18 years old
- Diagnosed with stable angina pectoris
- Anatomic vessel disease (VD) lesion with 2VD/3VD
- Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks of CABG surgery.
- Not planned to urgent CABG
- Minimum optimal medical therapy within 2 weeks
- Able and willing to sign informed consent and comply with study procedures
- The patient lives in Bandung City and its neighborhood
- Retired patient; or not actively working during working hours; or willing to take the time to participate in research.
Exclusion Criteria22
- Congestive Heart Failure
- Chronic heart failure with Functional Class NYHA III - IV
- LVEF <35%
- Unprotected left main stenosis >50%
- Blood pressure >180/110mmHg
- Acute coronary syndrome
- Acute Heart Failure
- Severe aorta regurgitation
- Malignant arrhythmia
- Atrial fibrillation
- Premature ventricular complex
- Peripheral occlusive artery disease
- Phlebitis
- Deep vein thrombosis
- Hemorrhagic diathesis
- Severe chronic kidney disease
- Aortic aneurysm
- Abdominal aneurysm
- Osteoarthritis
- Low back pain
- Pregnancy
- Registered as other clinical study participant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
ECP therapy consist of 36 session, each session @1 hour/day, five days a week with initial pressure of 300mmHg
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04873687